Aries Drugs

Rudrapur, India Founded: 2005 • Age: 21 yrs
Produces high-quality pharmaceutical products for the market.

About Aries Drugs

Aries Drugs was a Healthcare company based in Rudrapur (India) founded in 2005. It produces high-quality pharmaceutical products for the market. It operates on a B2B model. The company has 21 employees. Its Indian entity Aries Drugs Private Limited reported revenue of β‚Ή2.58 Cr. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Drug Manufacturing and Pharmaceutical Products.

Company details

Aries Drugs, founded in 2005 in Rudrapur, India, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and pharmaceutical products. Produces high-quality pharmaceutical products for the market. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

Key Metrics
  • Annual Revenue
    ₹2.58 Cr

    FY 2024 · -23% YoY

  • Net Loss
    -₹26.9 Lakh

    FY 2024 · -10% margin

  • EBITDA
    -₹8.4 Lakh

    FY 2024 · -3% margin

  • Employee Count
    21

Board of directors of Aries Drugs Private Limited (Aries Drugs)

Aries Drugs Private Limited is the primary company behind Aries Drugs. The board of Aries Drugs Private Limited currently have 4 directors; the longest-serving is Amit Agarwal, appointed in 2005. 7 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Amit Agarwal
DIN 00660463
Managing Director04 Apr 200521 yrs 6 moAries Drugs Private Limited
Hari Om Agarwal
DIN 00660604
Director21 Jan 20197 yrs 9 moAries Drugs Private Limited
Madan Lal Agarwal
DIN 08350695
Director02 May 20242 yrs 6 moAries Drugs Private Limited
Ronak Agrawal
DIN 10612219
Director02 May 20242 yrs 6 moAries Drugs Private Limited

Financials of Aries Drugs

Figures of Aries Drugs Private Limited, the primary company behind Aries Drugs, for FY 2024. Revenue was ₹2.58 Cr (-23% year on year). Net loss was -₹26.9 Lakh (-10% margin). EBITDA was -₹8.4 Lakh (-3% margin). Revenue has grown at a compounded annual rate of -7% over three years and -3% over five years.

  • ₹2.58 CrRevenue · FY 2024 · -23% YoY
  • -₹26.9 LakhNet loss · -10% margin
  • -₹8.4 LakhEBITDA · -3% margin
  • ₹87.2 LakhPaid-up capital
  • 21Employees (provident fund records)
  • -7%Revenue CAGR, 3 years
  • -3%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Aries Drugs Private Limited are on its company page.

Premium access

Detailed financial statements for Aries Drugs

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Aries Drugs

Aries Drugs was founded in 2005.

Aries Drugs is headquartered in Rudrapur, India. It is registered at Rudrapur, Uttarakhand, India.

Aries Drugs has 21 employees.

The primary company behind Aries Drugs, Aries Drugs Private Limited, reported revenue of β‚Ή2.58 Cr for FY 2024, down 23% year on year.

Aries Drugs, founded in 2005 in Rudrapur, India, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and pharmaceutical products. Produces high-quality pharmaceutical products for the market. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

Aries Drugs operates through Aries Drugs Private Limited.

The legal entities of Aries Drugs currently have 4 directors, including Madan Lal Agarwal, Ronak Agrawal, Hari Om Agarwal and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available